E
X4 Pharmaceuticals, Inc. XFOR
$3.18 $0.3813.57% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 5,721.31% -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue 5,721.31% -- -- -- --
Cost of Revenue 1,978.73% -- -- -- --
Gross Profit 9,121.36% -- -- -- --
SG&A Expenses 13.49% 29.33% 73.27% 75.17% 62.30%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 11.68% 25.46% 33.89% 22.34% 23.13%
Operating Income 14.33% 1.69% -31.51% -21.30% -22.57%
Income Before Tax -673.29% 111.58% 63.26% 84.99% 113.59%
Income Tax Expenses 258.33% 249.46% 297.44% 44.07% 380.00%
Earnings from Continuing Operations -678.36% 111.32% 62.98% 84.92% 113.52%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -678.36% 111.32% 62.98% 84.92% 113.52%
EBIT 14.33% 1.69% -31.51% -21.30% -22.57%
EBITDA 15.15% 2.44% -31.28% -21.30% -22.76%
EPS Basic -671.05% 110.85% 69.37% 89.36% 108.26%
Normalized Basic EPS -12.50% 35.87% -17.38% 23.50% 58.10%
EPS Diluted -680.37% 110.72% 69.23% 89.19% 108.12%
Normalized Diluted EPS -12.53% 35.89% -17.36% 23.52% 58.11%
Average Basic Shares Outstanding 4.42% 5.88% 13.20% 30.63% 59.66%
Average Diluted Shares Outstanding 4.48% 6.04% 13.25% 30.69% 59.73%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --